Avalo Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative therapies for rare and devastating diseases. The company utilizes its proprietary drug development platform to identify and advance treatments that target specific biological pathways, aiming to address unmet medical needs in various therapeutic areas. With a commitment to improving patient outcomes, Avalo works on a range of programs that include both preclinical and clinical-stage assets, striving to bring breakthrough solutions to market for patients with limited treatment options.